| Christopher J Arnold, MD | |
|
1300 Jefferson Park Ave, Charlottesville, VA 22903-3363 | |
| (434) 982-1700 | |
| (434) 982-4054 |
| Full Name | Christopher J Arnold |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 16 Years |
| Location | 1300 Jefferson Park Ave, Charlottesville, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326215443 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Virginia Medical Center | Charlottesville, VA | Hospital |
| Augusta Health | Fishersville, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Virginia Physicians Group | 4880590728 | 1397 |
News Archive
As the global media speculate on the number of people likely to inhabit the planet on Oct. 31 an international team of population and development experts argue that it is not simply the number of people that matters but more so their distribution by age, education, health status and location that is most relevant to local and global sustainability.
The Senate's Republican majority refused to agree to create a "health exchange," or state-based health insurance market required under President Barack Obama's health care overhaul, for individuals and small businesses to insure more Americans.
A group of researchers at Instituto de Medicina Molecular Lisboa has revealed the mechanism by which cellular nuclei reach their position within muscle cells.
Sanofi-aventis announced today that the investigational once-daily oral drug teriflunomide significantly reduced annualized relapse rate (ARR) at 2 years versus placebo in patients with relapsing multiple sclerosis (RMS), thus achieving the primary endpoint in the TEMSO phase III trial.
› Verified 2 days ago
| Entity Name | University Of Virginia Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
As the global media speculate on the number of people likely to inhabit the planet on Oct. 31 an international team of population and development experts argue that it is not simply the number of people that matters but more so their distribution by age, education, health status and location that is most relevant to local and global sustainability.
The Senate's Republican majority refused to agree to create a "health exchange," or state-based health insurance market required under President Barack Obama's health care overhaul, for individuals and small businesses to insure more Americans.
A group of researchers at Instituto de Medicina Molecular Lisboa has revealed the mechanism by which cellular nuclei reach their position within muscle cells.
Sanofi-aventis announced today that the investigational once-daily oral drug teriflunomide significantly reduced annualized relapse rate (ARR) at 2 years versus placebo in patients with relapsing multiple sclerosis (RMS), thus achieving the primary endpoint in the TEMSO phase III trial.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher J Arnold, MD Po Box 9007, Charlottesville, VA 22906-9007 Ph: () - | Christopher J Arnold, MD 1300 Jefferson Park Ave, Charlottesville, VA 22903-3363 Ph: (434) 982-1700 |
News Archive
As the global media speculate on the number of people likely to inhabit the planet on Oct. 31 an international team of population and development experts argue that it is not simply the number of people that matters but more so their distribution by age, education, health status and location that is most relevant to local and global sustainability.
The Senate's Republican majority refused to agree to create a "health exchange," or state-based health insurance market required under President Barack Obama's health care overhaul, for individuals and small businesses to insure more Americans.
A group of researchers at Instituto de Medicina Molecular Lisboa has revealed the mechanism by which cellular nuclei reach their position within muscle cells.
Sanofi-aventis announced today that the investigational once-daily oral drug teriflunomide significantly reduced annualized relapse rate (ARR) at 2 years versus placebo in patients with relapsing multiple sclerosis (RMS), thus achieving the primary endpoint in the TEMSO phase III trial.
› Verified 2 days ago
Daniel S. Strand, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1240 Lee St, Charlottesville, VA 22908 Phone: 434-243-5233 Fax: 434-244-7526 | |
Dr. Numaan F. Malik, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: Lee St Fl 2, Charlottesville, VA 22908 Phone: 434-924-5219 Fax: 434-924-9720 | |
Dr. Asma Shahid Habib, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1204 W Main St, Charlottesville, VA 22903 Phone: 434-924-9119 Fax: 434-924-3300 | |
Amber N. Inofuentes, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-243-4288 Fax: 434-243-7310 | |
Mark Thomas Worthington, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-243-3090 Fax: 434-244-9445 | |
Dr. Emanuel Cirenza, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 590 Peter Jefferson Place, Suite 175, Charlottesville, VA 22911 Phone: 434-982-6900 Fax: 434-982-8420 | |
Warren K. Bolton, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: Uva Hospital W, Hospital Drive, Charlottesville, VA 22908 Phone: 434-924-1984 Fax: 434-924-5898 |